Skip to main content
A

Allelix Biopharmaceuticals Inc. — Investor Relations & Filings

Ticker · ALX TSX Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSX ALX

About Allelix Biopharmaceuticals Inc.

https://www.allelix.com

Allelix Biopharmaceuticals Inc. was a biopharmaceutical research and development company focused on discovering and developing therapeutics using proprietary technologies. The company's core research programs centered on protein-based drugs and neuroscience, including the development of protein therapeutics. Notable development efforts included the glucagon-like peptide 2 (GLP-2) analog ALX-0600. Allelix Biopharmaceuticals was subsequently acquired and operated as NPS Allelix Inc., a subsidiary specializing in biopharmaceutical products.

Recent filings

No filings indexed yet

We are still gathering filings for Allelix Biopharmaceuticals Inc.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.